Merck (Germany) Today
| 6MK Stock | EUR 96.20 1.70 1.80% |
Performance4 of 100
| Odds Of DistressLess than 9
|
Merck is trading at 96.20 as of the 31st of January 2025. This is a 1.80 percent increase since the beginning of the trading day. The stock's lowest day price was 94.0. Merck has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Merck Co., Inc. operates as a healthcare company worldwide. Merck Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey. MERCK DL operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. The company has 2.54 B outstanding shares. More on Merck Co
Moving against Merck Stock
Merck Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Merck's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Merck or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Pres Chairman | Robert JD |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
Merck Co (6MK) is traded on Frankfurt Exchange in Germany and employs 67,000 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 254.37 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Merck's market, we take the total number of its shares issued and multiply it by Merck's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Merck classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 2.54 B outstanding shares.
Merck Co has accumulated about 7 B in cash with 19.09 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.76.
Check Merck Probability Of Bankruptcy
Ownership AllocationMerck maintains a total of 2.54 Billion outstanding shares. The majority of Merck outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Merck Co to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Merck. Please pay attention to any change in the institutional holdings of Merck as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Merck Ownership Details
Merck Risk Profiles
Although Merck's alpha and beta are two of the key measurements used to evaluate Merck's performance over the market, the standard measures of volatility play an important role as well.
Merck Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Merck without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
| All Next | Launch Module |
Merck Corporate Management
Elected by the shareholders, the Merck's board of directors comprises two types of representatives: Merck inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Merck. The board's role is to monitor Merck's management team and ensure that shareholders' interests are well served. Merck's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Merck's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cristal Downing | Ex Officer | Profile | |
| Jennifer Zachary | Exec Counsel | Profile | |
| David Williams | Ex Officer | Profile | |
| Caroline Litchfield | Ex CFO | Profile | |
| Lisa LeCointeCephas | VP Officer | Profile | |
| Richard DeLuca | Ex Health | Profile | |
| Kenneth Frazier | Ex Chairman | Profile |
Other Information on Investing in Merck Stock
Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.